The absence of FOS expression is associated with advanced stage, lymph node metastasis, lymphatic invasion, and shorter survival, indicating its loss during gastric cancer progression and its correlation with poor prognosis (Jin et al. 2007). Here, FOS is linked to metastatic malignant neoplasm in the lymph nodes.